Dermatology Portfolio

About Cosmo

Cosmo is a diversified life sciences company leveraging AI and digital health to advance therapeutics and technologies in dermatology, gastroenterology, and medical AI. With a business model encompassing proprietary drug development and contract manufacturing services, it targets significant unmet needs in gut and skin health. The company appears to be in a commercial stage, given its CDMO operations and focus on bringing therapies to market through partnerships.

About Deva Holdings

Founded in 1958, Deva Holdings has grown from a domestic Turkish pharmaceutical player into an internationally recognized, publicly traded generics and API manufacturer. Its strategy is built on vertical integration, a strong R&D focus on bioequivalence, and geographic expansion into over 80 countries. Key achievements include establishing a significant export business, maintaining a diverse portfolio spanning multiple therapeutic areas, and operating a large-scale, end-to-end production infrastructure. The company's mission, 'For lives we add health to...', underscores its commercial focus on affordable, accessible medicine.

Therapeutic Areas